The Blood Harvest


“Each year, half a million [of these creatures] are captured and bled alive to create an unparalleled biomedical technology.”

— The Atlantic

“Without them,” CNN says, “medicine would return to the dark ages.”

Their blood — crucial to both the medical and pharmaceutical communities — is worth an astounding $60,000 per gallon...

It could pay you upwards of 1,000%!


Dear Reader,

There's a prehistoric creature so crucial to modern medicine that its blood is worth an astounding $60,000 per gallon.

This ancient creature is a survivor — it predates dinosaurs by a full 200 million years and outlived them by another 250 million — but now it's very existence is under threat.

Thing is, the very defense mechanism that's kept them alive (and virtually unchanged) all these years is the reason they're in danger now...


Because as CNN puts it: “without them medicine would return to the dark ages.”

What exactly does this mean?

It means rampant infection, gangrene, amputations, and dramatically higher mortality rates.

You see, the reason these creatures have been around for so long is their incredible immune system — specifically the bacterial defense system harbored in their blood.

That's why hundreds of thousands of horseshoe crabs are bled alive with a large-gauge needle each and every year in the name of modern medicine…

And odds are, you’re alive today because of this strange creature:

“Components of this crab blood have a unique and invaluable talent for finding infection, and that has driven up insatiable demand,” says Popular Mechanics.

Their precious blood is even called “the medical equivalent of gold.” Check it out...


In fact, the whole of modern medicine, pharmacology included, is dependent on horseshoe crab blood... which is why their blood is worth an incredible $60,000 per gallon.

According to a recent PBS documentary, “Every drug certified by the FDA must be tested using [their blood],” as well as “surgical implants such as pacemakers and prosthetic devices.”

You see, this primitive creature's blood cells are so sensitive to bacteria that they can actually detect the presence of ANY bacterial contamination — even at a concentration of one part per trillion they’ll zero in on it like a homing missile.

Nothing else even comes close. It's the gold standard of bacteria, or endotoxin, testing.

According to the National Institutes of Health, there's no other compound that can test the purity of medicines and sterility of equipment with this level of accuracy...

And ONE company dominates this critical market... giving you the opportunity to literally invest in the lifeblood of modern medicine.

One of its largest customers is pharma giant Pfizer, but the truth is, “It works for every one of the 100 largest global drug developers,” says the Boston Globe.

Again, this technology is critical.

If you're wondering just how critical we're talking, know this — without these sensitive tests for biocontamination catastrophe occurs

Poorly tested pharmaceuticals are not only “a silent killer,” but the BBC says they're fast being recognized as “a global pandemic.”

This is exactly why federal law requires that any medical device inserted or injected into the human body, or any drug ingested, must first be tested for bacterial contamination...

We’re talking surgical equipment, syringes, prosthetic limbs, hip replacements, more than 1450 life-saving FDA-approved drugs, the list goes on — they're tested for bacteria with horseshoe crab blood.

Millions of Lives and Billions of Dollars at Stake

Frankly, you're probably alive today because of a horseshoe crab…

Or as Popular Mechanics says point blank: “Every man, woman and child and domestic animal on this planet that uses medical services is connected to the horseshoe crab.”

In fact, it's fair to say that modern medicine as we know it is founded on horseshoe crab blood.

And modern medicine is BIG BUSINESS. 

In the U.S. alone, the medical device market is worth $148 billion and this figure is expected to grow to $173 billion over the next year.

Prescription drugs are an even bigger business. Spending in that sector jumped 12% in 2015, reaching a record $425 billion for the year... and this figure is expected to push $610 billion over the next year or so.

This is precisely why horseshoe crab blue blood is worth $60,000 per gallon.

It's the lifeblood of the multibillion-dollar medical and pharmaceutical landscape, and it's priced accordingly...

And one company has emerged as THE clear leader in this market space, meaning some serious money-making potential for you.

As one venture capital firm likes to say, this company is “the Mercedes of the industry.”

In the coming months you can easily double your money or more from this company's unparalleled horseshoe crab blood breakthrough — and over time this indispensable company and steady stock could hand you a ten bagger.

I'll show you this incredible profit opportunity in a few minutes, but first I want to demonstrate once and for all how critical horseshoe crab blood is to medicine as we know it.

It's no wonder scientists are calling horseshoe crab blood a “modern medical miracle...”

But you can only understand what a true “irreplaceable medical marvel” it really is when you understand the catastrophic consequences of what happens without it...

“Killer Pharmacy: Inside a Medical Mass Murder Case”

- Newsweek

Imagine going to your local doctor for a routine procedure to manage your back pain...

And walking away with a pathogen that would eventually lead to your “horrific, torturous death.”

That's precisely what happened to 64 unsuspecting (and seriously unlucky) patients.

Within days, some developed spinal abscesses and suffered strokes. For others, severe symptoms would take up to three months to appear.

All in all, this outbreak sickened more than 800 people — and for 64 of them, it was a death sentence.

But this wasn't the early 1900s and it wasn't in a third world country.

This happened in the United States in 2012.

In fact, the final death count wasn't released until 2015.

People had gone to their doctor for a routine steroid shot to manage back pain, and they ended up being infected with fungal meningitis.

Whether you're dealing with “medical devices, pharmaceuticals or biologics,” expert industry analyst Contract Pharma says, “contamination is among the top areas of risk to public safety.”

This is EXACTLY why we need horseshoe crab blood.

And at the New England Compounding Center (NECC) where the steroid shots originated, caution — and proper testing procedures — were thrown to the wind.

The FDA affidavit states that NECC's on-site pharmacist used improper sterilization and testing techniques.

And as a result, a simple procedure turned deadly.

The cornerstone of efforts to combat this type of contamination is endotoxin testing via horseshoe crab blood.

Cornering the Blue Blood Market for 1,142% Gains


Add up all these “routine” procedures made so easy by horseshoe crab blood and you'll find that many millions of lives are at stake...

And many billions of dollars.

And today I'm going to show you the absolute best way to play this incredible medical breakthrough...

And why I can all but guarantee it will be a money maker.

The fact is, we've been here before.

Just a few years ago in-house, we alerted our readers to a similar profit opportunity...

In that case, it was a sea snail with a remarkable protein in its blood that's indispensable to roughly 100 drugs currently undergoing FDA trial.

It's helping to fight diseases like Alzheimer's and cancer — and investors that followed our recommendation earned an ample payday.

One reader, Geoffrey G., earned a rapid-fire 237% profit.

All told, the stock shot up 1,142% in less than two years. 

But the thing is, compared to horseshoe crabs, sea snails are a small player. Sea snail blood has only a fraction of the footprint that horseshoe crab blood does in the medical community...

Consider the 100 drugs that need sea snail blood in order to work...

A remarkable track record for sure, and again, one that's paid investors more than 1,142% — a ten bagger and then some.

But then consider that, as PBS says, “every drug certified by the FDA must be tested using Limulus amebocyte lysate.” (The scientific name for the horseshoe crab blood test).

Limulus Amebocyte Lysate (LAL) Test:

LAL binds and clots around fungi, viruses, and bacterial endotoxins, protecting horseshoe crabs and humans from infection.

The FDA's approved more than 1450 drugs to date... that alone is a bigger market impact by nearly 15 times. 

And horseshoe crab blood's also used to test devices like prosthetics, joint replacements, pacemakers, and flu shots. Even pet vaccines.

And while sea snail blood is used by one California company, medical systems worldwide rely on horseshoe crab blood to keep their drugs and equipment contamination free.

The “Red Hot” Sector Responsible for Creating Countless Ten Baggers

The sheer scope of this market is enormous — and incredibly valuable…

As well as incredibly consistent.

Which is why I believe we could safely double or triple our money in the short term, and even bank a ten bagger from this unique blue blood opportunity over the long haul.

Thing is, when you look at the biomedical market — a sector that Forbes calls “red-hot” because it's responsible for one ten bagger after another — it's important to note that most of these biomedical breakthroughs are only possible because of horseshoe crab blood

“From a regulatory standpoint,” says premier field publication Genetic Engineering and Biotechnology News, “biotech companies must demonstrate to the FDA and, increasingly, to the public, that their processes are under control with respect to microbe detection.”

And at this point in time, in order to do that you need horseshoe crab blood — again, it’s the common denominator making most medical breakthroughs possible.

We need these crabs to keep our medicines, our vaccines, our prosthetics, and other medical devices safe.

Which is why their blood is worth a whopping $60,000 per gallon.

And that's why the profits provided by this blue blood blue chip investment opportunity presented here today could pay you upwards of 1,000%.  

Here's What the Experts Have to Say…

“Horseshoe crab blood is an irreplaceable medical marvel... Components of this crab blood have a unique and invaluable talent for finding infection, and that has driven up an insatiable demand.”

-Popular Mechanics

“The U.S. Food and Drug Administration requires that intravenous drugs and any medical equipment coming in contact with the body must first pass through the crab's blood, from needles to surgical implants including pacemakers. As a result, thousands more of us survive such procedures."


“You’ve seen an IV bag? The solution in that bag has to be tested for the absence of pyrogens using [horseshoe crab blood]. So do the tubes and needles connecting the bag to the patient.”

-Scientific American

And according to Dr. Peter B. Armstrong, professor of molecular and cellular biology at the University of California:

“Nothing has gone to the level of FDA approval to show it is yet a viable alternative to the [horseshoe crab blood] test. Knowing the cost and difficulty of obtaining FDA tests, it may be some time before any alternative is out there on the market.”

And one company has this exclusive market all but cornered.

In fact, that Scientific American quote was actually talking about one company in particular's horseshoe blood compound — and it’s none other than the company I’m telling you about today.

It goes on to say that this specific company's test is “the most sensitive in the world.”

It can detect just a single bacterium among trillions of particles...

To put that in perspective, it's like finding a grain of sand in an Olympic-sized swimming pool — all in a matter of just a few minutes.

Bar none, this company's the global leader in endotoxin testing.

And it's no wonder, since it's the one that invented it in the first place and changed medicine forever.

Since then it's been one milestone after another.

Only One Company Has the Optimized Technology

Nowadays, not only does it have the most sensitive test, it's also the fastest-acting, giving results in only 5–15 minutes.

This is critical in a field where a matter of minutes can mean the difference between life and death.

Finally, this company's test is so advanced that it uses 20 times less crab blood than the next best test — the simple fact that this company can do more with less is especially important because of the shrinking supply of horseshoe crabs.

As Medical Daily grimly notes, “As horseshoe crab populations steadily decrease, their indispensable medical use is threatened.”

In fact, a recent study found that the horseshoe crab population in the Delaware Bay — not only the world's largest, but also the particular type of crab needed for the Limulus amebocyte lysate (LAL) test — has shrunk by 90% over the last 15 years.


Horseshoe crabs are now among the most protected creatures in the Eastern U.S.

Biologist Christopher Chabot, who led the study, says, “It's difficult because the blood is crucial for human health issues, but the biomedical industry needs to keep the population steady.”

The pioneering company I've been telling you about is doing precisely that by using 20 times less raw material than competitors.

“If all tests were performed using this optimized technology,says one company scientist, “today's entire world demand could be met with the blood collected from our current quota of animals.”

It also has the highest survival rate — 98% of the crabs it bleeds survive after being returned to the water.

Horseshoe crabs in Space

tcn_blood_harvest_img4This company's horseshoe crab blood test — the most advanced in the world — is also aboard the International Space Station.

In a comic book-like twist, the same company that saves millions of human lives each year with its horseshoe crab blood test is also preventing “sick” spaceships.

Astronauts use it to “perform biological studies necessary for an extended human presence in space — from crew health and spacecraft environmental studies to the search for life elsewhere in the solar system.”

And NASA used this company's horseshoe crab blood test to monitor for microbial contamination during the construction of the Mars exploration rovers, “Spirit” and “Opportunity.”

So this company could singlehandedly meet the world's medical demand for horseshoe crab blood, and help protect a threatened species.

As a matter of fact, there's such high demand for this company's expertise that it recently built a new 450,000-square-foot facility in order to meet it.

And I fully expect this increased operating power to be reflected in the share price.

The fact remains, one leading researcher says, “Today, the horseshoe crab’s blood is still the most sensitive, accurate and reliable detector of dangerous bacteria found in anything from flu vaccines to outer space.”

That’s right — this company’s horseshoe crab blood test is also used by NASA and is even aboard the International Space Station.

One company made this all possible, and this company is still the leader in this uniquely profitable sector. 

And the truth is — without the company that has made this all possible, our reality would look a lot different.

How Blue Blood Can Bankroll Your Retirement


This company is fundamental to one of the largest, richest, and most necessary market sectors ever — modern medicine.


Hi, my name is Jimmy Mengel.

And after the time I've spent uncovering uniquely profitable stock market opportunities, I can tell you that the more extraordinary (and direct) a company's impact — like horseshoe crabs saving human lives and enabling outer space missions — the more it tends to make waves in the investment community… 

And these waves grant investors a generous payday — as my regular readers can attest to...

They’ve followed my lead on the high seas of the stock market, and our hard work has paid off big time.

In fact, we’ve been having a record run.

While the S&P 500 returned a respectable 13% last year, The Crow's Nest managed to bank 1398% returns on our closed positions — on companies that, like the horseshoe crab blood situation, you'd probably have never heard of otherwise:

  • 3,480% on Canopy Growth Corp.
  • 380% on Cronos Capital Corp.
  • 126% on Liberty Health Sciences.
  • 100% on Boeing Company.
  • 68% on Piedmont Natural Gas Co. Inc.

I'd say that is a pretty good year...

Fact is, if you’d banked just one of these winners, you would have already put the S&P’s performance to shame.

If you banked them all (like we did), then you’d have trounced the S&P by more than 100 times!

Fact of the matter is, I take pride in my work… In unearthing these buried treasures and sharing them with a close-knit community of independent investors…

And I'll travel pretty much anywhere and do whatever leg work it takes to find them.

In the past year, I've traveled to Ontario, Canada to bring you boots-on-the-ground coverage from the budding medical marijuana sector.

I've received a backstage tour of the Collector’s Universe archives — chock-full of precious treasures like million-dollar stamps, hundred-thousand-dollar baseball cards, and priceless rare coins.

Here’s one picture from my trip. It’s me holding a one-million-dollar stamp: The Inverted Jenny. It’s the most valuable American stamp ever created.

I've appeared on investment panels on global trends in Toronto, cannabis in San Francisco, and I've given speeches on dividend investment plans in Orlando and Las Vegas.

Every trip I make, I make sure to come back with a new recommendation, a hot new sector, or simply the due diligence you need to be confident in a stock.

I've given six-figure presentations in front of Silicon Valley hotshots seeking my outlook on these one-of-a-kind money-making opportunities.

But a captain is nothing without his crew, and I've been privileged enough to hear from many crew members that have enjoyed — and profited from — my unique mix of stories, stocks, and suggestions.

Even the star of one of the most popular shows in TV history — who I won't name, to protect his privacy — is an avid reader.

Famous television host Montel Williams dropped by my office to discuss his interest in cannabis investing and biotechnology.

I even sat down with rock-and-roll legend Gene Simmons from KISS for an investment interview.

I also count the voice of ESPN SportsCenter host Chris Kelly as a fan. You no doubt recognize his iconic “This is SportsCenter!” opening from the last few decades.

In fact, he recently wrote in with some humbling praise.

“No one writing today has 'your clear voice,' keep shining your light... You are on fire these days, Jimmy!”

You see, Chris had been less than impressed with other newsletters out there. You know, the ones that try to get you hyped up about some penny stock or risky options strategy.

But, like Chris, I believe that investing isn't about beating the odds and making a million in two weeks. Investing is a lifelong skill that can never be taught too early.

“My kids are 22 and 20 and it's been a family education,” Chris writes. “I feel I am adding the one thing missing from my parenting through the years... finance, saving & investing.”

Of course, you don't have to be rich or famous to make full use of my advice. I believe it could make anyone — no matter your investing experience or how much you have in the bank — extraordinarily wealthy in the coming years.

And today, because of my experience, I'm the managing editor of one of the country's largest independent financial boutiques.

I head the Outsider Club and our financial planning advisory, The Crow's Nest.

And I'll be honest with you... I've never had much of a stomach for risk.

I'm terrible at poker and would never, ever buy a lottery ticket.

I invest the same way. My goals are to keep risk at a bare minimum and look outside the box to find unique, safe deals with tons of upside.

Fact is, in the famous fable of “The Tortoise and the Hare,” it’s the steadfast tortoise who wins the day... but many investors forget this lesson.

They get duped by hype and “get rich quick” schemes... but when I pick stocks, I’ll choose the trusty tortoise every time...

BUT that doesn’t mean you have to settle for sorry returns year after year.

Remember, my readers recently banked gains of 3,480%, 120%, and 380%.

So they know firsthand that you can keep risk out of the equation and still make a killing in the markets...

The only thing you have to do is be willing to think outside the box...

Like investor Jeannette C., who has been a member since the beginning and was even brave enough to join us on our annual Crow's Nest Pirate Cruise...

Jimmy, thank you so much for the subscriptions! I look forward to reading about your adventures (land or sea) and stock thoughts. I can't thank you enough, and I hope to have the Crow's Nest for the next 30+ years! Again, thank you, thank you, thank you.

Or like reader Sebastian G.

Ahoy Jimmy, Doubled my money in a week since joining the Crow's Nest. Well played. I look forward to the next one...

Or how about this recent note from investor Annette B.

Hi Jimmy, I’ve never bought a Canadian stock before, but am so glad I did this time. 110% on PharmaCan in less than a month! You’ve proven that it’s never too late to try something new!

Paul D. wrote to tell me:

Your service is simply outstanding!

Roy F. wrote in to say – that after decades of reading newsletters – the Nest was the best he’d ever seen:

I am really happy with Jimmy Mengel, I have over the last 30 years tried a lot of different financial news letters and they have all lost me money. I started to read Crow's Nest in March 2015 and now have stakes in 18 companies that — thanks to the Crow's Nest — show a very handsome profit!

Encouraging messages like these are what I live for, and day in and day out I do my best to genuinely earn them.

And frankly, as my wife and I raise two young kids of our own in this crazy — and increasingly expensive —  world, I can totally understand the lure of easy money... but I’d never in a million years bet my kids’ futures on it, and I invest with them in mind.

And I take the same approach when it comes to my readers.

Now, in no way, shape or form am I trying to compare do-it-yourself investors to children here, I only bring this up to point out the fact that I’d never tell my readers to put their money into some fly-by-night stock I wouldn’t be comfortable investing in myself.

The stocks I share with my readers are the very same ones I discuss with my wife at the kitchen table when we talk about our own family’s financial future...

And to that end, I have some very exciting plans for the future — starting with the company behind the horseshoe crab blood test. 

Blue Blood, Blue Chip: Your First Step to Financial Independence


You can read all about it in my latest special report: “Blue Blood, Blue Chip: Let the Lifeblood of Modern Medicine Help Bankroll Your Retirement.”

In this one-of-a-kind briefing, I’ll break down everything you need to know to take advantage of this one-of-a-kind opportunity — starting with the ticker symbol of the company I’ve been going on about:

  • The company that both pioneered and perfected the horseshoe crab blood test...
  • The company that makes the $148 billion medical device market possible...
  • The company that works with every single one of the world’s 100 largest drug developers — and that played a crucial role in more than half of the new FDA-approved medications from the last few years.

And this company shows no signs of slowing down... or of releasing the stranglehold it has on this critical market.

In fact, every year, these guys continue to outdo themselves:

If you’re looking to add steady growth to your retirement portfolio, this Blue Blood, Blue Chip stock is a no-brainer…

And, depending on your exact retirement timeline, you could handily triple your investment or even land a true-blue ten bagger.

Bar none, this stock has the best long-term value I’ve ever seen in a medical biotech...

A sector that Forbes calls “red-hot” because it's responsible for one ten bagger after another.

And my latest special report, “Blue Blood, Blue Chip: Let the Lifeblood of Modern Medicine Help Bankroll Your Retirement,” tells you what you need to know to tap into this best-of-breed stock in a uniquely profitable sector.

By joining The Crow’s Nest today, you’ll get instant access to all the critical details behind this Blue Blood Blue Chip money maker...

But this isn’t the only breakthrough medical opportunity I’ve been following recently.

Or the only special report you’ll receive today...

Bonus Report #1:
“The Big Black Book of Income”

This is possibly the most important book you’ll ever own. That’s because it reveals 27 sources of guaranteed income. Just one of these sources could send you a check every 30 days.

Folks who are in on these income streams are collecting checks like these...

  • $4,498 a month for John H.
  • $1,300 a month is mailed to Martin J.
  • $2,678 taken in every month by Markos T.
  • $3,195 is sent to Peter D. every month.

And remember, this special book is yours completely free of charge.

And that's not all you'll receive for free today, because I have another gift for you.

Bonus Report #2:
“The New Investor’s Guidebook to the ‘Underground Stock Market’”

For over 60 years now, there has been a secret, hidden “Underground Stock Market.”

A private stock exchange where you can buy publicly traded shares “off market” at a discount... with less risk... and practically guaranteed higher returns.

I’m talking about getting 177... 364... and even as much as 665 higher percentage points than on stocks you’d normally buy on the NYSE and NASDAQ.

I’m not talking about weird, fly-by-night penny stocks, pink sheets, or Silicon Valley startups run by kids out of a garage.

I’m talking about bona fide, trusted companies like American blue chips. S&P 500 corporations. Fortune 100 businesses. Mid-to-large-size caps with brands average people would recognize on the street.

...Except you’re getting higher (much higher) returns!

In this report, I also share my three core criteria for picking underground stocks. It’s not the same as choosing stocks on the regular stock market. There are quite a few extra things you need to look at.

This is also yours free.

Welcome to The Crow's Nest:
Outperforming the S&P by 100 Times

As I mentioned before, my name is Jimmy Mengel.

Nowadays, I head the financial planning advisory, The Crow's Nest...

But as a trained journalist, I've gained a reputation among my peers for digging like a sleuth to uncover under-the-radar moneymaking loopholes and financial back doors that most people never hear of...

In other words, I don't follow the crowd. The real money is always in the investments you've never heard of. That's how the rich play the game.

Whether it’s the $200 billion untapped potential of the marijuana market...

The emergence of cutting-edge medical developments that could change our lives and mint new fortunes...

Or retirement loopholes that can turn these profit windfalls into substantial "work-free" salaries...

I take pride in not just spotting life-changing trends long before the media catches wind...

But also helping everyday investors maximize their profits from these explosive opportunities.

Remember, just last year we banked 1,398% total gains... compared to the S&P 500’s 13% increase.

That’s what The Crow’s Nest is all about.

All the research, the meetings with executives, the boots-on-the-ground investigation...

Touring the shops... factories... and fields...

It’s all a lot of work that keeps me going nonstop.

But it’s all worth it, knowing that you — the everyday investor — can see the money you need to fund your retirement.

A subscription to my letter, by the way, costs $99 a year.

Remember, elite investors charge their clients thousands of dollars for their advice. With The Crow’s Nest, you will get access to their best picks without having to pay the hefty fees they charge.

That’s why many folks believe The Crow’s Nest offers the best deal you’re ever likely to come across for this kind of research.

But here’s the thing...

You can actually get started with a full-year subscription today for much less than our normal rate. Today, you can receive a full year of The Crow’s Nest, plus everything else I mentioned here, for only $69.

Why so cheap?

Well, I know that most of my readers, like me, are extremely skeptical. Lots of people can make big promises and talk a good game, but in my experience, very few can actually deliver on what they promise.

And I know that if you’re like me, I need to earn your trust and your business. That’s why I want to make it as easy, cheap, and hassle-free as possible for you to try my work today.

That’s why, instead of paying our regular rate of $99 per year, today you can pay just $69. That’s $0.19 a day to receive EVERYTHING I mentioned here.

This includes:

  • 12 Issues of The Crow's Nest: Delivered every month, each research letter I send you will be packed with the best elite investor ideas I uncover. I’ll also show you how to boost your income, incredible ways to dramatically cut your cost of living, the safest way to grow your retirement account, and much more.
  • Special Report: “Blue Blood, Blue Chip: Let the Lifeblood of Modern Medicine Help Bankroll Your Retirement.”
  • Bonus Report #1: “The Big Black Book of Income”
  • Bonus Report #2: “The New Investor’s Guidebook to the ‘Underground Stock Market’”
  • Unlimited Access: You'll get your very own password and username to The Crow's Nest platform, which gives you access to my research reports, newsletter archives, portfolio, and research videos.
  • Member Support: A direct line to our Customer Service Staff, available to answer your questions.
  • Special Alerts: Specific 'buy this, sell that' instructions — so you always know what steps to take next.

Oh, and one more thing...

When you try my research, I’m not asking you to commit to anything whatsoever.

All I expect when you sign up is that you’ll give my work a try.

Here’s the deal I’m proposing: sign up today to start receiving my research, and take the next 30 days to make up your mind.

If for any reason my work does not seem right for you, simply let me know within the next 30 days, and I’ll make sure you get a FULL REFUND for your entire $69 payment.

No restocking fee. Nothing to send back. Even if you cancel your subscription and receive a full refund, I’d like you to keep all the research you’ve received, my compliments.

Remember, even if you’ve subscribed to a financial letter before, I guarantee you’ve never seen anything like The Crow’s Nest.

I will introduce you to the best investment ideas, like our Blue Blood Blue Chip, and help you achieve financial freedom by taking complete control of your finances.

If this sounds like a fair deal to you, then thank you and welcome — simply click on the "Subscribe Now" button below, which will take you to a secure order form, where you can review everything you’ll receive before placing your order.

I look forward to hearing from you.



Jimmy Mengel
Investment Director, The Crow's Nest